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Résumé: 
Dysfonction de la valve aortique et dilatation de l'aorte chez les adultes avec une 
coarctation de l'aorte 
Objectif: Déterminer la prévalence de la dysfonction de la valve aortique, de la dilatation de 
l'aorte proximale et des interventions au niveau de la valve aortique et de l'aorte ascendante chez 
les adultes avec une coarctation de l'aorte. 
Contexte: La dysfonction de la valve aortique et la dilatation de l'aorte proximale sont rares 
chez les enfants et les adolescents avec une coarctation de l'aorte. A long terme, les adultes 
pourraient être plus à risque de développer ce type de pathologie. 
Méthode: Nous avons rétrospectivement passé en revue tous les adultes avec une coarctation de 
l'aorte corrigée ou pas suivis au« Boston Children's Hospital» entre 2004 et 2010. 
' 
Résultats: 216 adultes (56 % d'hommes) avec une coarctation ont été identifiés. L'âge médian à 
la dernière évaluation était de 28 (de 18 à 75) ans. Une bicuspidie aortique était présente dans 
66% des cas. Au dernier contrôle, 3% avaient une sténose aortique modérée ou sévère et 4% 
avaient une insuffisance aortique modérée à sévère. Une dilatation de la racine de l'aorte ou de 
l'aorte ascendante était présente dans 28%, respectivement 42% des patients. Une dilatation au 
moins modérée de la racine de l'aorte ou de l'aorte ascendante (score Z > 4) était présente dans 
8%, respectivement 14%. Les patients avec une bicuspidie aortique étaient plus sujets à avoir une 
dilatation au moins modérée de la racine de l'aorte ou de l'amie ascendante comparés à ceux 
sans bicuspidie (20% contre 0%; p<0.001). L'âge était associé à une dilatation de l'aorte 
ascendante (p=0.04). Au dernier suivi, 6% avait nécessité une intervention au niveau de la valve 
aortique et 3% un remplacement de la racine de l'amie ou de l'aorte ascendante. 
Conclusion: Chez les adultes avec une coarctation de l'aorte, une dysfonction significative de la 
valve aortique et des interventions sur la valve ou l'aorte proximale étaient peu fréquentes. 
Cependant, la dilatation de l'aorte était prévalente, en particulier au niveau de l'aorte ascendante 
chez les patients avec une bicuspidie aortique. 
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AB ST RA C T---------------------------------
Objectives. To determine the prevalence of aortic valve dysfunction, aortic dilation, and aortic valve and ascending 
aortic intervention in adults with coarctation of the aorta (CoA). 
Background. Aortic valve dysfunction and aortic dilation are rare among children and adolescents with CoA. With 
longer follow-up, adults may be more likely to have progressive disease. 
Metbods. We retrospectively reviewed ail adults with CoA, repaired or unrepaired, seen atour center between 2004 
and 2010. 
Results. Two hundred sixteen adults (56.0% male) with CoA were identified. Median age at last evaluation was 28.3 
(range 18.0 to 75.3) years. Bicuspid aortic valve (BAV) was present in 65.7%. At last follow-up, 3.2% had moderate 
or severe aortic stenosis, and 3. 7% had moderate or severe aortic regurgitation. Dilation of the aortic root or 
ascending aorta was present in 28.0% and 41.6% of patients, respectively. Moderate or severe aortic root or 
ascending aortic dilation (z-score > 4) was present in 8.2% and 13.7%, respectively. Patients with BAV were more 
likely to have moderate or severe ascending aortic dilation compared with those without BAV (19.5% vs. 0%; P < 
0.001). Age was associated with ascending aortic dilation (P = 0.04). At most recent follow-up, 5.6% had undergone 
aortic valve intervention, and 3.2% had aortic root or ascending aortic replacement. 
Conclusion. In adults with CoA, significant aortic valve dysfunction and interventions during early adulthood were 
uncommon. However, aortic dilation was prevalent, especially of the ascending aorta, in patients with BAV. 
Key Words. Coarctation of the Aorta; Bicuspid Aortic Valve; Aortic Dilation; Aortic Valve Dysfunction 
Introduction 
C oarctation of the aorta (CoA) is among the most common congenital cardiovascular 
defects, affecting 1 of 3 000 live births. 1•2 Long-term 
survivors are at risk for aortic and mitral valve 
dysfunction, aortic aneurysm, aortic dissection, 
endocarditis, systemic hypertension, heart failure, 
and sudden death. 3•4 Bicuspid aortic valve (BAV) 
is present in approximately two thirds of patients 
with CoA5·6 and is associated with increased risk 
for valvular dysfunction and aortic dilation. 3•7•8 
© 2013 Wiley Periodicals, Inc. 
Prior reports, however, suggest that children and 
adolescents with BAV and CoA are less likely to 
have aortic valve dysfunction and aortic dilation 
compared with those with isolated BAV6•9 and con-
sequently are less likely to require valvular inter-
vention or ascending aortic replacement. 10 As 
patients age, risks for developing valvular dysfunc-
tion and aortic dilation accrue. Therefore, we 
sought to determine the prevalence of aortic valve 
dysfunction, aortic dilation, and occurrence of val-
vular intervention or ascending aortic intervention 
in a population of adults with CoA. 
Congenit Hemt Dis. 2013; 80 :•._ .. 
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Methods 
Clinical databases in the cardiovascular program at 
Boston Children's Hospital were retrospectively 
searched to identify adults with repaired or unre-
paired CoA 218 years of age seen in the outpatient 
cardiology clinic between 2004 and 2010. We 
excluded patients with concomitant moderate or 
complex forms of congenital heart disease, 11 
Turner syndrome, 22q 11.2 deletion syndrome, 
Marfan syndrome, and related disorders such as 
Loeys-Dietz syndrome and Ehlers-Danlos syn-
drome, given their recognized association with 
aortic pathology. 12- 15 Patients with unicommis-
sural valve, defined as a complete or partial fusion 
of more than 2 leaflets, were excluded, as were 
patients with other lesions that could potentially 
alter the aortic valve, including subaortic stenosis16 
and infundibular, perimembranous, or outlet mus-
cular ventricular septal defects. 17 
Bicuspid aortic valve was defined as partial or 
complete fusion of 2 aortic valve leaflets, with 
or without a central raphe, resulting in partial or 
complete absence of that functional commissure. 18 
Systemic hypertension was considered present 
if the resting systolic blood pressure was 
> 140 mm Hg or the diastolic blood pressure 
>90 mm Hg at most recent clinic visit or if the 
patient was being treated with antihypertensive 
medication. The definition of CoA or recoarcta-
tion was based on conventional criteria, including 
documented repair, upper-to-lower-limb blood 
pressure gradient >20 mm Hg, and/or evidence of 
coarctation on imaging. 19,20 
The most recent echocardiogram (or the exam 
prior to any surgical or catheter intervention 
or endocarditis) was systematically reviewed. 
Echocardiographic assessment of aortic stenosis 
was expressed as the maximum instantaneous 
Doppler gradient (mm Hg) in the context of 
normal left ventricular contractile function. Crite-
ria for grading aortic stenosis (AS) and aortic 
regurgitation (AR) were taken from prior study.6 
Aortic stenosis was considered moderate or severe 
if the maximum instantaneous Doppler gradient 
was 250 mm Hg. Classification of the severity of 
AR was based on composite evaluation of proximal 
jet width, left ventricular end-diastolic volume or 
dimension, and abdominal aortic Doppler flow 
pattern. Designation of moderate or severe regur-
gitation required pandiastolic retrograde flow in 
the descending aorta and left ventricular end-
diastolic volume or dimension >2 standard devia-
tions above the mean, indexed to body surface area. 
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Gradient across the CoA (or arch obstruction) was 
assessed by blood pressure differential. Aortic mea-
surements were performed in parasternal long axis 
views using two-dimensional imaging, inner edge 
ta inner edge, at maximum (mid-systolic) excur-
sion. The aortic root was measured at largest 
dimension of the sinuses of Valsalva, and the 
ascending aorta was measured at the location of 
maximum diameter distal to the sinotubular junc-
tion. Aortic dimensions were adjusted for body 
surface area by dividing these dimensions by the 
square root of body surface area and were 
expressed as z-scores.21 Body surface area was cal-
culated using the formula by Haycock et al. 22 All 
echocardiograms with aortic dimensions missing 
from formal reports were reviewed by a single 
investigator (ARO). Mild aortic dilation was 
defined as z-score >2 and :::;4, and moderate or 
severe dilation as z-score >4. Additional clinical 
data regarding catheter and surgical interventions 
and diagnosis of endocarditis were obtained from 
medical records and hospital databases. The study 
protocol was approved by the Institutional Review 
Board at Boston Children's Hospital. 
Statistical Analysis 
Continuous data are presented as median (range) 
and were compared between two groups with 
Wilcoxon rank-sum tests. Categorical data are 
presented as counts and percentages, and rates 
were compared with chi-square tests and Fisher's 
exact tests. Univariate and multivariate logistic 
regression models were constructed to identify 
factors associated with aortic valve pathology. 
Candidate variables included valve morphology, 
age, sex, and history of hypertension. Logistic 
regression was used to identify factors associated 
with aortic root dilation and ascending aortic 
dilation, with the addition of clinically significant 
AR, clinically significant AS, and residual arch 
obstruction to the list of candidate variables. 
Two-tailed P values < 0.05 were considered sta-
tistically significant. Results are expressed as a 
fraction of available data. Data analysis was per-
formed with SAS software Version 9.2 (SAS 
Institute, Cary, NC, USA). 
Results 
A total of 216 adults (56.0% male) with CoA were 
identified. Characteristics of the study population 
are provided in Table 1. Median age at last evalu-
ation was 28.3 years (range 18.0 to 75.3). BAV was 
present in the majority (65.7%). In 20 (14.1 %) 
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Table 1. Baseline Characteristics of Patients with Coarctation of the Aorta 
Entire Cohort BAV No BAV 
Cohort Cohort Cohort Pvalue 
Size Size Size (BAV vs. 
n n n no BAV) 
Demographics 216 142 142 74 74 
Age in years, median (range) 28.3 (18.0-75.3) 27.4 (18.0-71.6) 30.2 (18.0-75.3) .46 
Male gender, n (%) 121 (56.0) 83 (58.5) 38 {51.4) .32 
BAV morphology 142 
R-L fusion 107 (75.4) 
R-N fusion 14 {9.9) 
L-N fusion 1 {0.7) 
Unknown morphology 20 (14.1) 
Intervention, n (%) 216 142 142 74 74 
Any surgical or catheter valve intervention 12 {5.6) 12 (8.5) 0 {O) .01 
Aortic valve catheter intervention 4 (1.9) 4 (2.8) 0 (0) .30 
Aortic valve surgical intervention 11 (5.1) 11 (7.8) 0 {O) .02 
Aortic root or ascending aorta intervention 7 {3.2) 7 (4.9) 0 (0) .10 
Clinical, n (%) 
Hypertension 214 107 {50.0) 140 64 (45.7) 74 43 {58.1) .08 
Prier coarctation repair 216 209 (96.8) 142 138 (97.2) 74 71 (96.0) .69 
Arch obstruction 193 14 (7.3) 125 9 (7.2) 68 5 (7.4) 1.0 
On antihypertensive treatment 210 91 (43.3) 138 55 (39.9) 72 36 (50) .16 
ARB/ACEI 57 (27.1) 33 {23.9) 24 (33.3) .15 
P-blockers 53 {25.2) 33 (23.9) 20 {27.8) .54 
Diuretics 13 (6.2) 7 (5.1) 6 (8.3) .38 
Calcium channel blocker 10 (4.8) 8 (5.8) 2 {2.8) .50 
a-blockers 3 (1.4) 1 (0.7) 2 (2.8) .27 
ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin Il receptor blockers; BAV, bicuspid aortic valve; L-N, left and noncoronary leaflet; R-L, right and 
left coronary leaflet; R-N, right coronary and noncoronary leaflet. 
patients with BAV, the subtype could not be ascer-
tained; in all others, fusion of right and left coro-
nary leaflets (R-L commissural fusion) was most 
common. 
Aortic Valve Dysfunction 
Echocardiographic data were available for 189 
(87. 5 % ) patients. Aortic valve dysfunction was 
present in 74/189 (39.2%). AS was present in 
39/189 (20.6%), and 6/189 (3.2%) patients had 
moderate or severe AS. AS was significantly more 
frequent in patients with BAV (31.5% vs. 0.0%, 
P < .0001) compared with patients with a tricus-
pid aortic valve. Moderate or severe AS was 
uncommon and present in 4.8% of patients with 
BAV and 0.0% of those without BAV (P = .10). 
As depicted in Figure lA and in Table 2, AS was 
present in 23.2% of patients with R-L commis-
sural fusion compared with 66. 7% with fusion of 
the commissure between the right coronary and 
noncoronary leaflets (R-N commissural fusion) 
(P = .004). 
Aortic regurgitation was present in 53/189 
(28.0%) patients and moderate or severe AR in 
7/189 (3.7%) patients. AR was more prevalent in 
patients with BAV (37.1 % vs. 10.8%, P < .0001). 
Moderate or severe AR was uncommon, present in 
4.8% of patients with BAV and 1.5% of those 
without (P = .43). The proportion of patients with 
AR was similar in those with R-L commissural 
fusion compared with those with R-N commis-
sural fusion (38.4% vs. 33.3%, P = 1.0). Male sex 
was associated with a higher prevalence of aortic 
regurgitation (P = .02). 
Older age, arch obstruction, and hypertension 
were not associated with aortic valve dysfunction. 
Aortic Root and Ascending Aortic Di/ation 
Aortic dilation was present in 82/183 (44.8%) 
patients. Moderate or severe aortic dilation was 
present in 311183 (16.9%) patients. 24.4% of 
patients with BAV had moderate or severe dilation 
compared with 3.1 % of patients without BAV 
(P < .001). 
Aortic root dilation was present in 511182 
(28.0%) patients, 15/182 (8.2%) of whom had 
moderate or severe dilation. The presence of BAV 
(P < .001) was associated with aortic root dilation. 
There was no statistically significant difference 
in prevalence of moderate or severe aortic root 
dilation between patients with and without BAV 
(P = .09, Table 3). Aortic root dilation was 
more prevalent in patients with AR (P = .02), as 
well as in patients with R-L commissural fusion, 
Congenit Herwt Dis. 2013; .. :•L•• 
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Figure 1. (A) Proportion of patients with aortic stenosis or aortic regurgitation by valve morphology. (B) Proportion of 
patients with aortic root or ascending aortic dilation by valve morphology. Aortic dilation is defined as a z-score of >2. Error 
bars represent the 95% confidence interval. See Tables 2 and 3 for statistical comparison and multivariable analysis. AR, 
aortic regurgitation; AS, aortic stenosis; BAV, bicuspid aortic valve; R-L, right and left coronary leaflet. 
Table 2. Factors Associated with Valve Dysfunction 
Valve Dysfunction, 
Univariate Multivariate 
n n (%) Odds Ratio (95% Cl) p Odds Ratio (95% Cl) p 
Aortic stenosis 
Valve morphology 
Tricommissural 65 0 (0) Reference <.0001 Reference <.0001 
R-L fusion 99 23 (23.2) 27.3 (4.6, oo)* 24.3 (4.1, oo)* 
Other BAV 25 16 (64.0) 142.1 (21.6, oo)* 115.6 (17.6, oo)* 
Age (per 5 years increase) 1.02 (0.9, 1.2) .76 
Gender 
Male 103 21 (20.4) Reference .93 
Female 86 18 (20.9) 1.03 (0.5, 2.1) 
Systemic hypertension 
No 97 20 (20.6) Reference .96 
Yes 91 19 (20.9) 1.02 (0.5, 2.1) 
Arch obstruction 
No 160 27 (16.9) Reference .89 
Yes 13 2 (15.4) 0.9 (0.2, 4.3) 
Aortic regurgitation 
Valve morphology 
Tri commissural 65 7 (10.8) Reference .001 Reference .002 
R-L fusion 99 38 (38.4) 5.2 (2.1, 12.5) 5.1(2.1,12.4) 
Other BAV 25 8 (32.0) 3.9 (1.2, 12.3) 3.7 (1.2, 11.8) 
Age (per 5 years increase) 1.0 (0.9, 1.1) .97 
Gender 
Male 103 36 (35.0) Reference .02 Reference .03 
Fern ale 86 17 (19.8) 0.5 (0.2, 0.9) 0.5 (0.2, 0.9) 
Systemic hypertension 
No 97 25 (25.8) Reference .55 
Yes 91 27 (29.7) 1.2 (0.64, 2.3) 
Arch obstruction 
No 160 43 (26.9) Reference .15 
Yes 13 6 (46.2) 2.3 (0.7, 7.3) 
*Estimated using exact logistic regression. 
BAV, bicuspid aortic valve; R-L fusion, right and left coronary leaflet fusion; =, infinity. 
compared with those with other types of BAV 
(P < .001, Figure lB). 
Ascending aortic dilation was present in 67 /161 
(41.6%) patients, with 22/161 (13.7%) having 
Congenit Hean Dis. 2013; .. :•--•• 
moderate or severe dilation. Older age (P = .001) 
and presence of BAV (P < . 0001) were significantly 
associated with ascending aortic dilation (Table 4). 
The presence of BAV was also associated with at 
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Table 3. Factors Associated with Aortic Root Dilation (z-score > 2) 
Dilated 
Univariate Multivariate 
n n (%) Odds Ratio (95% Cl} p Odds Ratio (95% Cl) P 
Valve morphology 
Tricommissural 64 8 (12.5} Reference <.001 Reference <.001 
R-L fusion 94 39 (41.5) 5.0 (2.1, 11.6) 5.0 (2.1, 11.6) 
Other BAV 24 4 (16.7} 1.4 (0.4, 5.2) 1.4 (0.4, 5.2} 
Age (per 5 years increase) 1.1 (1.0, 1.3) .08 
Gender 
Male 99 31 (31.3) Reference .28 
Fern ale 83 20 (24.1} 0.70 (0.4, 1.3) 
Aortic stenosis 
No 145 40 (27.6) Reference .80 
Yes 37 11 (29.7) 1.1 (0.5, 2.5) 
None or mild 176 49 (27.8} Reference 1.00 
Moderate or severe 6 2 (33.3) 1.3 (0.1, 9.4)* 
Aortic regurgitation 
No 131 30 (22.9} Reference .02 
Yes 51 21 (41.2) 2.4 (1.2, 4.7) 
None or mild 175 47 (26.9} Reference .10 
Moderate or severe 7 4 (57.1) 3.6 (0.8, 16.8) 
Systemic hypertension 
No 95 21 (22.1) Reference .06 
Yes 86 30 (34.9) 1.9 (1.0, 3.6) 
Arch obstruction 
No 155 41 (26.5) Reference .26 
Yes 12 5 (41.7) 2.0 (0.6, 6.6} 
*Estimated using exact logistic regression. 
BAV, bicuspid aortic valve; R-L fusion, right and left coronary leaflet fusion. 
Table 4. Factors Associated with Ascending Aorta Dilation (z-score > 2) 
Dilated 
Univariate Multivariate 
n n (%) Odds Ratio (95% Cl) p Odds Ratio (95% Cl) p 
Valve morphology 
Tricommissural 48 8 (16.7) Reference <.001 Reference <.0001 
R-L fusion 90 47 (52.2) 5.5 (2.3, 13.0) 9.3 (3.4, 25.6} 
Other BAV 23 12 (52.2} 5.5 (1.8, 16.6) 8.7 (2.4, 30.7) 
Age (per 5 years increase) 1.3 (1.1, 1.5) .001 1.4 (1.2, 1.7) <.0001 
Gender 
Male 90 33 (36.7} Reference .15 
Female 71 34 (47.9) 1.6 (0.8, 3.0} 
Aortic stenosis 
No 125 47 (37.6} Reference .06 
Yes 36 20 (55.6) 2.1 (1.0,4.4) 
None or mild 155 63 (40.7} Reference .39 
Moderate or severe 6 4 (66.7} 2.9 (0.4, 33.0)* 
Aortic regurgitation 
No 111 43 (38.7) Reference .27 
Yes 50 24 (48.0) 1.5 (0.7, 2.9} 
None or mild 154 65 (42.2) Reference .48 
Moderate or severe 7 2 (28.6} 0.5 (0.1, 2.9) 
Systemic hypertension 
No 85 36 (42.4) Reference .90 
Yes 75 31 (41.3} 1.0 (0.5, 1.8) 
Arch obstruction 
No 136 53 (39.0) Reference .46 
Yes 12 6 (50.0} 1.6 (0.5, 5.1} 
*Estimated using exact logistic regression. 
BAV, bicuspid aortic valve; R-L fusion, right and left coronary leaflet fusion. 
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least moderate dilation of the ascending aorta 
(19.5% vs. 0%; p < .001). 
Arch obstruction and hypertension were not 
associated with aortic root and/or ascending aortic 
dilation. 
Interventions 
Twelve (5.6%) patients had a total of 22 aortic 
valve interventions; six underwent more than 2 
interventions. Occurrence of aortic valve interven-
tion was associated with BAV (P = .01). Bicuspid 
aortic valve with R-N commissural fusion was 
more likely to require intervention compared with 
BAV with R-L commissural fusion (P= .002). Four 
patients had balloon valve dilation as a first inter-
vention, and all but one patient had a surgical valve 
intervention. The indication for initial valve inter-
vention (catheter-based or surgical) was AS in 8 
patients and AR in 4, including 1 with concomi-
tant ascending aorta replacement. Endocarditis 
precipitated 3 operations. In addition, 7 patients 
had ascending aorta or root intervention; all pre-
sented with aortic dilation at time of surgery. First 
valve intervention occurred in 2 patients during 
the first year oflife, in early childhood (2 .5 and 4.4 
years old) in 2, between ages 11 and 15 years in 3, 
and after age 18 years in the remaining 5. 
Discussion 
Progressive aortic valve dysfunction and aortic 
dilation in patients with CoA place patients at 
increased risk for morbidity and mortality.3 The 
results of our study extend understanding of the 
disease course, with particular application to 
younger adults, given the population captured in 
this cohort. The key findings of our study are as 
follows: (1) mild valve dysfunction is frequent, but 
significant aortic valve dysfunction is uncommon, 
in a selected population of young adults with CoA; 
(2) aortic dilation is prevalent, especially of the 
ascending aorta, in patients with a BAV; (3) preva-
lence of valvular or aortic pathology appears to 
follow recognized pediatric patterns of association 
with type of BAV commissural fusion; and (4) 
aortic valve or ascending aortic interventions are 
uncommon but do occur during adolescence and 
young adulthood. 
Aortic Valve Dysfunction 
Most young adults with CoA remain free of sig-
nificant valvular dysfunction. Although mild AS 
and AR were prevalent in our patients with BAV, 
moderate or severe aortic valve dysfunction was 
Congenit Heart Dis. 2013; .. :•._ .. 
Clair et al. 
rare. In contradistinction, Toro-Salazar et al. 
reported that in long-tenn follow up >50 years 
after CoA repair, valvular and aortic pathologies 
were common; in their cohort, 10/92 subjects had 
moderate or severe aortic valve dysfunction.23 
Given the relatively young age of our cohort, 
that some degree of aortic valve dysfunction 
was common, and that increased prevalence of 
aortic valve dysfunction has been associated 
with aging,24-27 continued cardiac surveillance 
appears appropriate in this population. These 
data, however, cannot determine, but may help 
refine, recommendations for appropriateness, fre-
quency, and nature of long-term monitoring. 
Our findings on valve morphology are consis-
tent with the premise that R-L commissural fusion 
and R-N commissural fusion represent different 
disease entities with distinct developmental 
causes. 6,2s-3o We demonstrate that two thirds of 
patients with CoA have a BAV and that the major-
ity of BAVs are of the R-L commissural fusion 
type. Moreover, we show that R-N commissural 
fusion was associated with greater valve dysfunc-
tion and was more likely to compel valve interven-
tion compared with R-L commissural fusion. Also, 
there was a higher prevalence of aortic root dila-
tion in patients with an R-L fusion pattern. These 
results lend further credence to the concept that 
different phenotypic patterns are associated with 
the two common BAV morphologies. 
Aortic Root and Ascending Aortic Di/ation 
Even after successful repair of CoA, patients may 
present with evidence of vascular dysfunction31 
and abnormal vascular structure.32 Our findings of 
a larger aortic root and ascending aorta in patients 
with associated BAVs are consistent with prior 
reports suggesting that BAV is a predictor of aortic 
wall complications in subjects with CoA.28,33 The 
association between systemic arterial hypertension 
and aortic complications, derived largely from 
study of older subjects with greater degree of 
atherosclerosis, remains controversial28'34 and is 
not supported by our data, obtained largely from 
a current and younger adult population. Arch 
obstruction, associated with increased wall stress 
in the proximal aorta, was also not found in our 
analysis to impact aortic size. In part, these results 
lend support to the paradigm that aortic dilation 
is not exclusively determined by hemodynamic 
parameters and that intrinsic anomalies of the 
aortic wall may be important in pathologie devel-
opment for patients with CoA and BAV35,36 
Importantly, despite increasingly characterized 
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disorders of vascular connective tissue involving 
loss of elastic tissue in bath of these congenital 
pathologies,37 clinical consequences appear some-
what discordant. We and others8 have found that 
the largest aortas may be present in patients with 
BAVs alone, and the smallest may be present in 
patients with solitary CoA. Further studies are 
required to better elucidate pathophysiological 
mechanisms associated with aortic dilation and its 
complications in these settings. 
In patients with bath tricuspid aortic valve and 
BAV, age correlates with cystic medial necrosis, 
fragmentation of elastic fibers, and aortic dila-
tion. 8•34•38 Indeed, in our cohort with CoA, older 
age was associated with increased ascending aortic 
size. Given the large number of young patients 
with CoA and BAV with milder degrees of aortic 
dilation, the potential for further dilation with 
advancing age is concerning. 
Interventions 
Valve interventions were uncommon. Of patients 
who did have an intervention, just under half had 
their first valve intervention in adulthood. We 
have previously reported that congenital severely 
dysfunctional valves tend to be intervened on in 
childhood. 10 In adulthood, we were more likely to 
encounter consequences of degenerative changes. 
The process may be accelerated by interactions 
with cardiovascular risk factors that increase the 
risk of developing worsening of AS and have 
prompted calls for increased vigilance for and 
treatment of such risks.24 Notably, guidelines and 
indication for intervention on bath BAV and CoA 
in younger and middle-aged adults remain rela-
tively free of data that support optimal timing for 
such; assessment of comparative outcomes with 
or without intervention for these patients is 
welcomed. 
While only 7 patients in our young-adult 
cohort underwent a surgical repair of aortic dila-
tion, intervention was more common in older 
patients. The need for intervention may be antici-
pated to increase as this population ages and as 
recommendations for surgical intervention prog-
ress to lower aortic diameter.28•39-42 
Given the lack of longitudinal data for this 
population we recognize the need for a prospec-
tive study of pathology and outcomes in adults 
with CoA, with or without BAV Most recent data 
suggest that this population remains at increased 
risk for other comorbidities such as systemic 
hypertension, heart failure, and coronary artery 
disease.43 •44 It therefore appears prudent to remain 
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vigilant, promoting lifelong cardiovascular surveil-
lance and optimal health practices in accordance 
with management guidelines.43•44 However, our 
results suggest that in general, patients with mild 
aortic dilation require less frequent follow-up; this 
appears particularly applicable to those with con-
comitant tricuspid aortic valve. 
Limitations 
Our study represents a single-center retrospective 
experience in a largely younger adult population. 
There is a referral bias, as patients with more 
severe disease or symptoms tend to be referred to 
regional centers. Aortic dimensions were unavail-
able in 33 (15.3%) patients; analysis failed to iden-
tify differences between baseline characteristics in 
subjects with and without data on aortic dimen-
sions, suggesting limited impact on our findings. 
Conclusion 
In this population of young adults with CoA, sig-
nificant aortic valve dysfunction and aortic valve or 
ascending aortic interventions were uncommon, 
though some degree of aortic dilation and valve 
dysfunction was relatively frequent. As adults with 
CoA acquire comorbidities with aging, they 
remain vulnerable to progressive valvular dysfunc-
tion and aortic dilation, especially in association 
with BAV Recommendation for sustained cardio-
vascular surveillance guided by specialists in BAV 
and aortic disease care appears prudent.43 Longi-
tudinal study and analysis of valve and aortic 
pathology in adults with CoA are needed to 
improve guidelines for disease-specific care and 
follow-up. 
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Rapport de synthèse: 
Dysfonction de la valve aortique et dilatation de l'aorte chez les adultes avec une 
coarctation de l'aorte 
La coarctation de l'aorte est parmi les malformations congénitales cardiovasculaires les plus 
fréquentes, affectant un nouveau-né sur 3000. Les survivants à long terme sont à risque de 
dysfonction valvulaire mitrale et amiique, d'anévrisme et de dissection aortique, d'endocardite, 
d'hypertension artérielle, d'insuffisance cardiaque et de mort subite. La bicuspidie aortique est 
présente dans deux tiers des patients avec une coarctation de l'aorte et est associée à un risque 
augmenté de dysfonction valvulaire aortique et dilatation de l'aorte. Cependant des études ont 
montré que dans l'enfance et l'adolescence les patients pmieurs d'une bicuspidie amiique et 
d'une coarctation de l'amie étaient moins sujets à une dysfonction de la valve aortique ou une 
dilatation de l'aorte proximale que ceux porteurs uniquement d'une bicuspidie. En conséquence, 
ces patients étaient également moins à risque de nécessiter une intervention sur la valve aortique 
ou un remplacement de l'aorte ascendante. Ce groupe de patients devenant plus âgés, le risque de 
développer une dysfonction valvulaire et une dilatation de l'aorte augmente. Nous avons donc 
cherché à déterminer la prévalence de la dysfonction de la valve aortique, de la dilatation de 
l'aorte proximale et des interventions,au niveau de la valve aortique et de l'amie ascendante chez 
les adultes avec une coarctation de l'aorte. 
Notre étude étend la compréhension de l'évolution de la maladie, en pmiiculier chez les 
jeunes adultes au vu de la population étudiée dans cette cohorte. Les trois principales conclusions 
de l'étude sont: 1) Un dysfonction légère de la valve aortique est fréquente mais une dysfonction 
impmiante est rare dans cette population sélectionnée de jeunes adultes. 2) La dilatation amiique 
est prévalente, en particulier au niveau de l'amie ascendante chez les patients avec une 
bicuspide. 3) La prévalence de pathologies amiique et valvulaire semble suivre des modèles 
reconnus, dans la population pédiatrique, en fonction du type de fusion commissurale. 4) les 
interventions sont peu fréquentes, durant l'adolescence et l'âge adulte. 
Etant donné l'absence de données longitudinales pour cette population, nous reconnaissons 
le nécessité d'études prospectives sur le devenir des adultes avec une coarctation avec ou sans 
bicuspidie aortique. Les données le plus récentes suggèrent que cette population est à risque pour 
d'autres comorbidités telles que l'hypertension artérielle, l'insuffisance cardiaque et la maladie 
coronarienne. Il apparait prudent de rester vigilant, de promouvoir le suivi cardiovasculaire à vie 
et d'optimiser la prise en charge en accord avec les recommandations établies par les sociétés 
savantes. Cependant, nos résultats suggèrent qu'en général, les patients avec une légère dilatation 
de l'aorte ascendante nécessitent un suivi moins fréquent; ceci est particulièrement vrai pour 
ceux p01ieur d'une'·valve aortique tricuspide. 
En conclusion, dans cette population de jeunes adultes avec une coarctation de l'a01ie, une 
dysfonction significative de la valve aortique et des interventions de la valve aortique ou l'aorte 
ascendante étaient rare. Cependant, un certain degré de dilatation aortique et de dysfonction 
valvulaire aortique étaient relativement fréquent. Etant donné que les adultes avec une 
coarctation de l'aorte vont développer des comorbidités avec l'âge, il reste vulnérable à une 
progression de la dysfonction valvulaire et à une dilatation de l'a01ie, en particulier ceux avec 
une bicuspidie a01iique. Recommander une surveillance cardiovasculaire guidée par un 
spécialiste dans la prise en charge des cardiopathies congénitales chez ces adultes paraît 
prudents. Des études longitudinales sont nécessaires pour améliorer les directives de prises en 
charge et de suivi spécifique à cette pathologie. 
